Researcher from Princess Royal University Hospital Provides Details of New Studies and Findings in the Area of Cystic Fibrosis (Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in...).

Předmět:	CYSTIC fibrosis UNIVERSITY hospitals DIGESTIVE system diseases GLUCOSE DIABETES
Zdroj:	Respiratory Therapeutics Week; 7/3/2023, p227-227, 1p
Abstrakt:	Keywords: Antidiabetic Agents; Antihyperglycemics; Cystic Fibrosis; Diagnostics and Screening; Digestive System Diseases and Conditions; Dipeptidyl Peptidase 4 Inhibitors; Drugs and Therapies; Health and Medicine; Lung Diseases and Conditions; Pancreatic Diseases and Conditions; Peptide Hormones; Peptide Proteins; Pharmaceuticals; Proinsulin; Respiratory Tract Diseases and Conditions; Sitagliptin Therapy EN Antidiabetic Agents Antihyperglycemics Cystic Fibrosis Diagnostics and Screening Digestive System Diseases and Conditions Dipeptidyl Peptidase 4 Inhibitors Drugs and Therapies Health and Medicine Lung Diseases and Conditions Pancreatic Diseases and Conditions Peptide Hormones Peptide Proteins Pharmaceuticals Proinsulin Respiratory Tract Diseases and Conditions Sitagliptin Therapy 227 227 1 07/03/23 20230703 NES 230703 2023 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Current study results on cystic fibrosis have been published. We studied 25 CF patients with abnormal OGTT results and compared glucose and insulin levels during the OGTTs with CGM results as a tool for early CFRD diagnosis. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu